⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GALT News
Galectin Therapeutics Inc.
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
globenewswire.com
GALT
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
National Survey: Veterinary Professionals See Stem Cell Therapy as a Powerful New Tool for Inflammatory Diseases in Pets
prnewswire.com
GALT
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis and Portal Hypertension, on March 10, 2026 at 12:00 PM ET
globenewswire.com
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT
accessnewswire.com
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT
accessnewswire.com
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT
accessnewswire.com
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of - GALT
accessnewswire.com
GALT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT
prnewswire.com
GALT